Teva Pharmaceutical: Dividends, Earnings And Valuation Analysis
. . . .
Teva Pharmaceutical (TEVA): A Dividend Contender with 13 Consecutive Years of Dividend Increases
Since dividends are paid out of earnings, a clear perspective of a company’s historical earnings growth record is a vital component of a dividend investor’s prudent due diligence process. The following graph plots Teva Pharmaceutical’s earnings per share since 1998. A quick glance to the right of the graph shows that Teva Pharmaceutical has increased earnings at a compounded rate of 23.1% (see purple circle on graph) per annum.
. . . .
(Click here to view entire article on Seeking Alpha.)
Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on Fastgraphs.com constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on Fastgraphs.com. Fastgraphs.com is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.